Finally FDA Standards for Generics are Questioned

I don’t know about you, but with my health issues I’ve been a big time consumer of prescription drugs for years. And I’ve almost always noticed the difference between the effectiveness of generics vs name brand on my body.  When I’ve asked my doctors what they take, they take brand for the same reason. Now I read that the FDA rigidly applies a standard of “bioequivalence” when testing generics . That is, the generic must deliver the same active ingredient, in the same amount, at the same rate as the original brand drug. This does not take into account “therapeutic equivalence”, which is the abililty of the two drug formulations to ease symptoms or cure disease. The inactive ingredients can result in variations  in the various formulations and effects of various generics made by various manufacturers.  I don’t know about you, but as a patient and a consumer various variations don’t make me feel warm, fuzzy and safe. The kicker here is that generics are touted as copycat drugs, or replicas of the originals. They’re not.  Read the whole article in todays LA Times.



One Response to “Finally FDA Standards for Generics are Questioned”

  1. amberfireinus Says:

    Well… something medically I didnt know. Thank you psychscribe… I will immediately investigate!

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: